Article
Regimen of cisplatin, vinblastine, temozolomide, IL-2, and INFa-2b shows to be active and well tolerated
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
The Latest Trends in Laser and Energy-Based Dermatology
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Three A’s Framework Offers Practical SDOH Solutions
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
In Memory of Robert Sidbury, MD, MPH
Reviewing Hemangiomas and Capillary Malformations and their Associated Risks